DTG in Subjects with HIV Exhibiting RAL Resistance: Functional Monotherapy Results of VIKING Study Cohort II
{"Image DocumentName": "DTG in Subjects with HIV Exhibiting RAL Resistance: Functional Monotherapy Results of VIKING Study Cohort II", "Image ImageDescription": "dolutegravir (DTG, S/GSK ), nouvelle anti int\u00e9grase, efficace chez les patients d\u00e9j\u00e0 r\u00e9sistants \u00e0 l Isentress.", "Image XResolution": "37", "Image YResolution": "37", "Image ResolutionUnit": "Pixels/Centimeter", "Image Software": "SlidePlayer", "Image YCbCrPositioning": "Centered"}